June 24, 2026
In the second episode of The Sequence, we sit down with Illumina CEO Jacob Thaysen to explore his journey into leadership—and how his team’s mission-driven mindset improves outcomes for patients and families around the world.
Thaysen shares why he has consistently gravitated toward the biggest challenges—and how, over time, that drive evolved into a deeper focus on solutions to help patients and families facing serious disease. He reflects on Illumina’s broader commitment to advance care, expand access, and deliver meaningful impact in areas such as cancer and rare disease.
Against the backdrop of rapid advances in AI and our growing understanding of biology, the conversation highlights how Illumina—through both leadership and innovation—is evolving beyond sequencing to deliver more seamless workflows, helping make genomic insights more actionable and accessible at the point of care.
Hosted by Adrian Benjamin, a leader in Illumina’s high‑throughput sequencing business, this discussion dives deep into the link between customer centricity and product strategy. Don’t miss it.
NOW AVAILABLE ON SPOTIFY
Catch up on Episode 1! Hear Chief Technology Officer Steve Barnard—the company’s fourth employee and first scientist—talk about the waves of innovation shaping Illumina today.
